ASSET | DATE | % RETURN |
---|---|---|
Monopar Therapeutics (MNPR) | 12/9/2019 - 12/20/2019 | 223.35% |
Mirum Pharmaceuticals (MIRM) | 12/9/2019 - 12/20/2019 | 169.37% |
Sobr Safe (SOBR) | 12/9/2019 - 12/20/2019 | 140.79% |
Neurogene (NGNE) | 12/9/2019 - 12/20/2019 | 122.5% |
Quince Therapeutics (QNCX) | 12/9/2019 - 12/20/2019 | 120.27% |
Axsome Therapeutics (AXSM) | 12/9/2019 - 12/20/2019 | 118.52% |
Immunitybio (IBRX) | 12/9/2019 - 12/20/2019 | 110.9% |
BW LPG (BWLP) | 12/9/2019 - 12/20/2019 | 87.47% |
Aptose Biosciences (APTO) | 12/9/2019 - 12/20/2019 | 84.75% |
AYRO (AYRO) | 12/9/2019 - 12/20/2019 | 84.62% |
VistaGen Therapeutics (VTGN) | 12/9/2019 - 12/20/2019 | 81.36% |
Barnwell Industries (BRN) | 12/9/2019 - 12/20/2019 | 80.23% |
IGM Biosciences (IGMS) | 12/9/2019 - 12/20/2019 | 76.9% |
Verb Technology (VERB) | 12/9/2019 - 12/20/2019 | 73.81% |
Kaival Brands Innovations (KAVL) | 12/9/2019 - 12/20/2019 | 71.43% |
Civeo (CVEO) | 12/9/2019 - 12/20/2019 | 67.07% |
Applied Digital (APLD) | 12/9/2019 - 12/20/2019 | 66.67% |
Venus Concept (VERO) | 12/9/2019 - 12/20/2019 | 66.31% |
Tarena International (TCTM) | 12/9/2019 - 12/20/2019 | 63.31% |
Adial Pharmaceuticals (ADIL) | 12/9/2019 - 12/20/2019 | 57.14% |
Assertio Therapeutics (ASRT) | 12/9/2019 - 12/20/2019 | 56.71% |
Immunovant (IMVT) | 12/9/2019 - 12/20/2019 | 55.91% |
Empire Petroleum (EP) | 12/9/2019 - 12/20/2019 | 54.56% |
Grace Therapeutics (GRCE) | 12/9/2019 - 12/20/2019 | 54.3% |
Clearside Biomedical (CLSD) | 12/9/2019 - 12/20/2019 | 52.12% |